VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
FIHL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
FIHLFidelis Insurance Holdings Limited
$23.06$2.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksFIHLQuarterly Financials

Fidelis Insurance Holdings Limited (FIHL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Fidelis Insurance Holdings Limited (FIHL) quarterly income statement — complete revenue, gross profit & net income history

FIHL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q1'22
Revenue600.9M650.2M591.3M577.5M680.3M681.3M537.5M445.8M548.8M539.9M453.1M2.05B2.05B316.8M
Revenue Growth %-11.67%-4.56%10.01%29.54%23.96%26.19%18.63%-78.26%-73.28%--547.19%--
Medical Costs & Claims183.2M447.1M536.3M597.1M0531.8M440M318.5M387.7M413.1M333M288.8M385.7M246.1M
Medical Cost Ratio %30.49%68.76%90.7%103.39%0%78.06%81.86%71.44%70.65%76.51%73.49%14.09%18.78%77.68%
Gross Profit417.7M203.1M55M-19.6M680.3M149.5M97.5M127.3M161.1M126.8M120.1M1.76B1.67B70.7M
Gross Margin %69.51%31.24%9.3%-3.39%100%21.94%18.14%28.56%29.35%23.49%26.51%85.91%81.22%22.32%
Gross Profit Growth %-38.6%35.85%-43.59%-115.4%322.28%17.9%-18.82%-92.77%-90.34%--2391.51%--
Operating Expenses274.8M42.3M32.8M30.7M819.8M31.6M34.6M32.2M35.3M31.2M29.1M26.7M-40.1M46.2M
OpEx / Revenue %45.73%6.51%5.55%5.32%120.51%4.64%6.44%7.22%6.43%5.78%6.42%1.3%-1.95%14.58%
Depreciation & Amortization00000000000100K0600K
Combined Ratio %76.22%75.27%96.25%108.71%120.51%82.69%88.3%78.67%77.08%82.29%79.92%15.39%16.83%92.27%
Operating Income142.9M160.8M22.2M-50.3M-139.5M117.9M62.9M95.1M125.8M95.6M91M1.73B1.71B24.5M
Operating Margin %23.78%24.73%3.75%-8.71%-20.51%17.31%11.7%21.33%22.92%17.71%20.08%84.61%83.17%7.73%
Operating Income Growth %202.44%36.39%-64.71%-152.89%-210.89%23.33%-30.88%-94.52%-92.64%--6980.82%--
EBITDA157.5M175.9M31.5M-41.6M-131.8M126.8M71.5M103.7M134.7M104.6M100M1.73B1.72B25.1M
EBITDA Margin %26.21%27.05%5.33%-7.2%-19.37%18.61%13.3%23.26%24.54%19.37%22.07%84.62%83.57%7.92%
Interest Expense14.6M15.1M9.3M8.7M7.7M8.9M8.6M8.6M8.9M9M9M8.6M8.2M8.8M
Non-Operating Income-14.6M-15.1M-9.3M-8.7M-7.7M-8.9M-8.6M-8.6M-8.9M-9M-9M-8.6M-8.1M-8.8M
Pretax Income142.9M160.8M22.2M-50.3M-139.5M117.9M62.9M95.1M125.8M95.6M91M1.73B1.71B24.5M
Pretax Margin %23.78%24.73%3.75%-8.71%-20.51%17.31%11.7%21.33%22.92%17.71%20.08%84.61%83.17%7.73%
Income Tax25.1M30.3M2.5M-7.8M-17.3M17.3M9.2M13.9M-102.5M7.9M7.1M2.2M-4.4M4.7M
Effective Tax Rate %17.56%18.84%11.26%15.51%12.4%14.67%14.63%14.62%-81.48%8.26%7.8%0.13%-0.26%19.18%
Net Income117.8M130.5M19.7M-42.5M-122.2M100.6M53.7M81.2M228.3M87.7M83.9M1.73B1.72B17M
Net Margin %19.6%20.07%3.33%-7.36%-17.96%14.77%9.99%18.21%41.6%16.24%18.52%84.5%83.72%5.37%
Net Income Growth %196.4%29.72%-63.31%-152.34%-153.53%14.71%-36%-95.31%-86.72%--10091.76%--
EPS (Diluted)1.171.240.18-0.38-1.090.880.460.691.930.740.7614.698.640.09
EPS Growth %207.34%40.91%-60.87%-155.07%-156.48%18.92%-39.47%-95.3%-77.66%--17081.29%--
EPS (Basic)1.181.250.18-0.38-1.090.880.460.691.940.750.7614.698.850.09
Diluted Shares Outstanding101.07M105.01M109.14M111.54M111.73M114.73M117.63M118.35M118.25M117.98M110.83M117.91M199.11M198.9M